MPN Research Foundation Opens 2026 MPN Challenge Funding Cycle
Key claim: The MPN Research Foundation has opened its 2026 MPN Challenge funding cycle, offering $200,000 two-year grants across projects including SLAMF7 immunotherapy, CAR-T for myelofibrosis, antibody responses, neutrophil biomarkers, and AI-based bone marrow assessment.
Abstract
MPN Research Foundation (MPNRF) announced opening of the MPN Challenge funding cycle as of January 6, 2026, offering two-year grants totaling $200,000. Projects span immunotherapy for SLAMF7, CAR-T approaches for myelofibrosis, anti-cancer antibody responses, neutrophil biomarkers for disease progression, and AI-based bone marrow assessment tools.
Why this matters
Pending synthesis.